Category: Diabetes
Oceania Diabetes
-
Asia Pacific Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare)
... and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare) The Asia Pacific glucose monitoring devices market is expected to grow from US$ 3,386.90 million in 2022 to US$ 8,471.46 million by 2030. It ... Read More
-
Australia In Vitro Diagnostics Market Assessment By Product Type [Instruments, Reagents & Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Haemostasias, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Ophthalmology, Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... Application [Ophthalmology, Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F Australia in vitro diagnostics ... Read More
-
Physician Office Diagnostic Market, By Product Type (Point-of-Care Testing (POCT) Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, and Urinalysis Systems), By End User (Physician Offices and Clinics, Urgent Care Centers, and Ambulatory Care Centers), By Application (Infectious Diseases, Cardiovascular Disorders, Metabolic Disorders, Cancer Diagnosis, Pregnancy and Fertility Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... By Application (Infectious Diseases, Cardiovascular Disorders, Metabolic Disorders, Cancer Diagnosis, Pregnancy and Fertility Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) POCT enables quick and accurate diagnostic testing with ... Read More
-
Allogeneic Stem Cell Transplantation Market, By Source (Bone Marrow, Peripheral Blood, Umbilical Cord Blood, Adipose Tissue, Dental Pulp, Others), By Application (Cancer, Autoimmune Diseases, Blood Disorders, Cardiac Disorders, Neurological Disorders, Diabetes, Others), By End User (Hospitals, Research Institutes, Specialty Clinics, Others), By Cell Type (Allogeneic MSCs, Allogeneic HSCs, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... (Hospitals, Research Institutes, Specialty Clinics, Others), By Cell Type (Allogeneic MSCs, Allogeneic HSCs, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Allogeneic stem cell transplantation is a medical ... Read More
-
Australia & South Korea Diabetic Foot Ulcer Market Size and Forecasts (2020 - 2030), Country Share, Trends, and Growth Opportunity Analysis Coverage By: Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-Ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Mild, Moderate, and Severe), End User (Hospitals, Ambulatory Surgery Centers, and Home Care), and Country
... Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Mild, Moderate, and Severe), End User (Hospitals, Ambulatory Surgery Centers, and Home Care), and Country The Australia & South Korea diabetic foot ulcer market is projected ... Read More
-
Australia Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 776 million by 2028, growing at a CAGR of 2.46% during the forecast period (2023-2028). The COVID-19 pandemic positively impacted the Australia Diabetes Care Devices Market growth. Patients with diabetes, infected with ... Read More
-
Australia And New Zealand Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion in 2023 to USD 1.27 billion by 2028, at a CAGR of 2.70% during the forecast period (2023-2028). Key Highlights A holistic study of the market studied has been carried out by incorporating various ... Read More
-
Australia Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 939.07 million by 2028, growing at a CAGR of 3.60% during the forecast period (2023-2028). The COVID-19 epidemic boosted the expansion of the Australia Diabetes Care Drugs Market. Diabetes patients infected with ... Read More
-
Asia-Pacific Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 20.99 billion by 2028, at a CAGR of 2.68% during the forecast period (2023-2028). The Asia-Pacific region has witnessed an astounding increase in the prevalence of diabetes in patients, in recent years. The increasing ... Read More
-
New Zealand Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023 to USD 357.92 million by 2028, at a CAGR of 2.60% during the forecast period (2023-2028). The likelihood of having type 1 diabetes increased when COVID-19 was discovered. Young pediatric patients and older adult ... Read More
-
Asia-Pacific Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 28.67 billion by 2028, at a CAGR of 3.10% during the forecast period (2023-2028). COVID-19 caused a gradual rise in demand for diabetes medications in the Asia-Pacific region. Patients with COVID-19 and pre-existing diabetes ... Read More
-
Australia Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 775.73 million by 2028, at a CAGR of 2.40% during the forecast period (2023-2028). During the COVID-19 pandemic, patients with diabetes were at higher risk for hospitalizations and complications due to hyper- or hypoglycemia, ... Read More
-
New Zealand Insulin Drugs And Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... million in 2023 to USD 546.59 million by 2028, at a CAGR of 1.10% during the forecast period (2023-2028). After COVID-19 was detected, the risk of developing type 1 diabetes increased. The largest risk was ... Read More
-
New Zealand Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 839.07 million by 2028, at a CAGR of 4% during the forecast period (2023-2028). Type 1 diabetes was more likely to occur after being diagnosed with COVID-19. Young pediatric patients and older adult patients ... Read More
-
New Zealand Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 495.73 million by 2028, at a CAGR of 3.30% during the forecast period (2023-2028). An individual's risk of infection, including other viral infections like the flu, is increased by diabetes. If they get COVID-19, ... Read More
-
Smart Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global smart medical devices market is witnessing remarkable growth, fueled by continuous advancements in digital health technologies and innovative customer-centric products. Smart medical devices utilize cutting-edge digital, networking, and sensor technologies to monitor, manage, ... Read More
-
Health Coaching Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global health coaching market is witnessing significant growth as consumers worldwide become increasingly aware of the benefits of disease prevention and maintaining a healthy lifestyle. Health coaching services, provided by trained professionals to help individuals ... Read More
-
Diabetic Food Market Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global prevalence of diabetes has been steadily increasing, with over 530 million adults affected in 2021. This alarming trend has prompted government authorities, healthcare organizations, and the public to focus on adopting a healthy ... Read More
-
Infusion Pump Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... demand for infusion pumps is being driven by a rising number of hospitalizations, increasing prevalence of chronic diseases, and the growing aging patient population worldwide. The global infusion pump market is expected to experience significant ... Read More
-
Global Autoinjectors Market (4th Edition), 2021-2035 Distribution by Type of Autoinjector (Disposable and Reusable), Route of Administration (Subcutaneous and Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Therapeutic Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts
... Rheumatoid Arthritis, Migraine, Diabetes, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts According to the National Health Interview Survey (NHIS), nearly 52% of the adult ... Read More
-
Oral Proteins and Peptides Market (4th Edition) by Target Disease Indication (acromegaly, celiac disease, chronic idiopathic constipation, enteric hyperoxaluria, inflammatory bowel disease and type II diabetes), Type of Molecule (protein and peptide), Technology Platforms, Biological Target (GC-C, insulin receptor, oxalate and others), Mechanism of Action (receptor stimulation, substrate degradation and others) Key Players and Key Geographical Regions (North America, Europe, Asia-Pacific and RoW), 2022-2032
... Target (GC-C, insulin receptor, oxalate and others), Mechanism of Action (receptor stimulation, substrate degradation and others) Key Players and Key Geographical Regions (North America, Europe, Asia-Pacific and RoW), 2022-2032 INTRODUCTION Since the approval of the ... Read More
-
New Zealand Insulin Drugs and Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)���
... of more than 4%. After COVID-19 was detected, the risk of developing type 1 diabetes increased. The largest risk was in young pediatric and older adult patients with COVID-19. Type 1 diabetic patients were more ... Read More
-
New Zealand Diabetes Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... An individual's risk of infection, including other viral infections like the flu, is increased by diabetes. If they get COVID-19, a diabetic patient will likely develop a serious illness and may even pass away. Diabetes ... Read More
-
New Zealand Self-Monitoring Blood Glucose Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... more than 5.2%. The COVID-19 pandemic showed that diabetes needs a lot more attention if we don't want the infection to cause problems that aren't necessary or fair.All the steps needed to protect this high-risk ... Read More
-
New Zealand Diabetes Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... Type 1 diabetes was more likely to occur after being diagnosed with COVID-19. Young pediatric patients and older adult patients with COVID-19 had the highest risk. Patients with type 1 diabetes were more likely to ... Read More
Research Assistance
